Dietary supplements reduce the risk of cervical intraepithelial neoplasia

International Journal of Gynecological Cancer

Volumn 20, Issue 3, 2010, Pages 398-403

  Hwang, Jong Ha ^a   Kim, Mi Kyung ^b   Lee, Jae Kwan ^a  

^a Korea University College of Medicine   (South Korea)

^b National Cancer Center   (South Korea)

Author keywords

CIN; Dietary supplements; HPV; Multivitamins; Viral load

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CALCIUM; MULTIVITAMIN; RETINOL; VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIET SUPPLEMENTATION; DNA DETERMINATION; FEMALE; FOOD INTAKE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK REDUCTION; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS LOAD; VITAMIN SUPPLEMENTATION; WART VIRUS;

ADOLESCENT; ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIETARY SUPPLEMENTS; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; VIRAL LOAD; YOUNG ADULT;

EID: 77952202310     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181d02ff2     Document Type: Article

References (22)

1. Franco EL, Rohan TE, Villa LL. Epidemiologic evidence and human papillomavirus infection as a necessary cause of cervical cancer. J Natl Cancer Inst. 1999;91:506-511.
2. Koutsky LA, Holmes KK, Critchlow CW, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med. 1992;327:1272-1278.
3. Schiffman MH, Brinton LA. The epidemiology of cervical carcinogenesis. Cancer. 1995;76:1888-1901.
4. Nagata C, Shimizu H, Yoshikawa H, et al. Serum carotenoids and vitamins and risk of cervical dysplasia from a case-control study in Japan. Br J Cancer. 1999;81:1234-1237.
5. Schiff MA, Patterson RE, Baumgartner RN, et al. Serum carotenoids and risk of cervical intraepithelial neoplasia in southwestern American Indian women. Cancer Epidemiol Biomarkers Prev. 2001;10:1219-1222.
6. Goodman MT, Kiviat N, McDuffie K, et al. The association of plasma micronutrients with the risk of cervical dysplasia in Hawaii. Cancer Epidemiol Biomarkers Prev. 1998;7:537-544.
7. Lehtinen M, Luostarinen T, Youngman LD, et al. Low levels of serum vitamins A and E in blood and subsequent risk for cervical cancer: interaction with HPV seropositivity. Nutr Cancer. 1999;34:229-234.
8. Sedjo RL, Roe DJ, Abrahamsen M, et al. Vitamin A, carotenoids, and risk of persistent oncogenic human papillomavirus infection. Cancer Epidemiol Biomarkers Prev. 2002;11:876-884.
9. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287:2114-2119.
10. Kim YO, Kim MK, Lee SA, et al. A study testing the usefulness of a dish-based food-frequency questionnaire developed for epidemiological studies in Korea. Br J Nutr. 2009;101:1218-1227.
11. Korea Health Industry Development Institute, Ministry of Health and Welfare. Development of Nutrient Database, Recipe, and Portion Size [In Korean]. Seoul, Korea: Korea Health Industry Development Institute, Ministry of Health and Welfare; 2000.
12. Norman HA, Butrum RR, Feldman E, et al. The role of dietary supplements during cancer therapy. J Nutr. 2003;133:3794SY3799S.
13. Greenwald P, Anderson D, Nelson SA, et al. Clinical trials of vitamin and mineral supplements for cancer prevention. Am J Clin Nutr. 2007;85:314SY317S.
14. Velicer CM, Ulrich CM. Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review. J Clin Oncol. 2008;26:665-673.
15. Ziegler RG, Jones CJ, Brinton LA, et al. Diet and the risk of in situ cervical cancer among white women in the United States. Cancer Causes Control. 1991;2:17-29.
16. Sun CA, Liu JF, Wu DM, et al. Viral load of high-risk human papillomavirus in cervical squamous intraepithelial lesions. Int J Gynaecol Obstet. 2002;76:41-47.
17. Ylitalo N, Sorensen P, Josefsson AM, et al. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet. 2000;355:2194-2198. (Pubitemid 30394326)
18. Schlecht NF, Trevisan A, Duarte-Franco E, et al. Viral load as a predictor of the risk of cervical intraepithelial neoplasia. Int J Cancer. 2003;103:519-524.
19. Lorincz AT, Castle PE, Sherman ME, et al. Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet. 2002;360:228-229.
20. Flores R, Papenfuss M, Klimecki WT, et al. Cross-sectional analysis of oncogenic HPV viral load and cervical intraepithelial neoplasia. Int J Cancer. 2006;118:1187-1193.
21. Josefsson AM, Magnusson PK, Ylitalo N, et al. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet. 2000;355:2189-2193. (Pubitemid 30394325)
22. Hernandez BY, McDuffie K, Wilkens LR, et al. Diet and premalignant lesions of the cervix: evidence of a protective role for folate, riboflavin, thiamin, and vitamin B12. Cancer Causes Control. 2003;14:859-870.